A comprehensive microarray profiling in lung, liver, breast cancer revealed a significant up-regulation of LINC00152 in liver (2.7-fold), lung (2.0-fold) and breast (1.8-fold) cancer compared to healthy tissue of the respective organs (Fig. 3a). Here, CYTOR is linked to cancer.